Tag: experience studies

The Mortality After Release from Incarceration Consortium (MARIC): Protocol for a multi-national, individual participant data meta-analysis

Mary Pat Campbell

Link: https://ijpds.org/article/view/1145

doi: 10.23889/ijpds.v5i1.1145

Graphic:

Excerpt:

Abstract

Introduction
More than 30 million adults are released from incarceration globally each year. Many experience complex physical and mental health problems, and are at markedly increased risk of preventable mortality. Despite this, evidence regarding the global epidemiology of mortality following release from incarceration is insufficient to inform the development of targeted, evidence-based responses. Many previous studies have suffered from inadequate power and poor precision, and even large studies have limited capacity to disaggregate data by specific causes of death, sub-populations or time since release to answer questions of clinical and public health relevance.

Objectives
To comprehensively document the incidence, timing, causes and risk factors for mortality in adults released from prison.

Methods
We created the Mortality After Release from Incarceration Consortium (MARIC), a multi-disciplinary collaboration representing 29 cohorts of adults who have experienced incarceration from 11 countries. Findings across cohorts will be analysed using a two-step, individual participant data meta-analysis methodology.

Results
The combined sample includes 1,337,993 individuals (89% male), with 75,795 deaths recorded over 9,191,393 person-years of follow-up.

Conclusions
The consortium represents an important advancement in the field, bringing international attention to this problem. It will provide internationally relevant evidence to guide policymakers and clinicians in reducing preventable deaths in this marginalized population.

Author(s): Borschmann, R., Tibble, H., Spittal, M. J., Preen, D., Pirkis, J., Larney, S., Rosen, D. L., Young, J. T., Love, A. D., Altice, F. L., Binswanger, I. A., Bukten, A., Butler, T., Chang, Z., Chen, C.-Y., Clausen, T., Christensen, P. B., Culbert, G. J., Degenhardt, L., Dirkzwager, A. J., Dolan, K., Fazel, S., Fischbacher, C., Giles, M., Graham, L., Harding, D., Huang, Y.-F., Huber, F., Karaminia, A., Kouyoumdjian, F. G., Lim, S., Møller, L., Moniruzzaman, A., Morenoff, J., O’Moore, E., Pizzicato, L. N., Pratt, D., Proescholdbell, S. F., Ranapurwala, S. I., Shanahan, M. E., Shaw, J., Slaunwhite, A., Somers, J. M., Spaulding, A. C., Stern, M. F., Viner, K. M., Wang, N., Willoughby, M., Zhao, B. and Kinner, S. A. 

Publication Date: February 2020

Publication Site: International Journal of Population Data Science

Group Life COVID-19 Mortality Survey Report

Mary Pat Campbell

Link: https://www.soa.org/4a368a/globalassets/assets/files/resources/research-report/2022/group-life-covid-19-mortality-03-2022-report.pdf

Graphic:

Excerpt:

Tables 2.1 through 2.41 display high-level incidence results for the second quarter of 2020 through the first quarter of 2022 compared to the 2017-2019 baseline period for each combination of (a) incurred/reported basis and (b) count/amount basis as of March 31, 2022. In these tables, the number of COVID-19 claims has not been adjusted for seasonality, but the ratios to baseline have been adjusted for seasonality.


Note that additional data reported in April and May 2022 indicated that the 1Q 2022 excess mortality would likely complete downward from the 19.9% shown below using March data. The fully complete 1Q 2022 excess mortality is expected to remain above 15%.

….

The 24-month period of April 2020 through March 2022 showed the following Group Life mortality results:
• Estimated reported Group Life claim incidence rates were up 20.0% on a seasonally-adjusted basis
compared to 2017–2019 reported claims.
• Estimated incurred Group Life incidence rates were 20.9% higher than baseline on a seasonally-adjusted
basis. As noted above, the incurred incidence rates in February and March 2022 are based on fairly
incomplete data, so they are subject to change and should not be fully relied upon at this point.

Author(s):

Thomas J. Britt, FSA, MAAA
Paul Correia, FSA, MAAA
Patrick Hurley, FSA, MAAA
Mike Krohn, FSA, CERA, MAAA
Tony LaSala, FSA, MAAA
Rick Leavitt, ASA, MAAA
Robert Lumia, FSA, MAAA
Cynthia S. MacDonald, FSA, MAAA, SOA
Patrick Nolan, FSA, MAAA, SOA
Steve Rulis, FSA, MAAA
Bram Spector, FSA, MAAA

Publication Date: August 2022

Publication Site: SOA

Old Age Mortality Experience Study Report

Mary Pat Campbell

Link: https://www.soa.org/resources/experience-studies/2022/old-age-mortality/

Graphic:

Excerpt:

The Society of Actuaries (SOA) Research Institute released a report that examines older age mortality (OAM) with a focus on attained ages 70 and above. The report helps determine whether refinements were needed in the 2015 Valuation Basic Tables. Analysis was performed by sex, issue age and attained age, issue year cohorts, smoking risk classification, benefit band, select vs ultimate period, and interactions.

Author(s):

Old Age Mortality Subgroup of the Individual Life Experience Committee

Publication Date: October 2022

Publication Site: Society of Actuaries

2021 Milliman Variable Annuity Mortality Study

Mary Pat Campbell

Link: https://www.milliman.com/en/insight/2021-Milliman-Variable-Annuity-Mortality-Study

Excerpt:

Milliman Variable Annuity Mortality Study shows mortality increases of 11% as a result of COVID-19 pandemic

Life insurers and annuity writers are now beginning to understand the impact of the COVID-19 pandemic on their lines of business, as mortality data for the year 2020 is reported and analyzed. While the pandemic has affected different carriers in different ways, future mortality rates are a key assumption for annuity writers.

With Milliman’s acquisition of Ruark Consulting in December 2021, the industry’s leading variable annuity mortality study has been rebranded as the Milliman Variable Annuity Mortality Study. The study is based on data from 2008 through 2020, totaling $674 billion in account value as of the end of the study period, with over 1 million deaths across 19 companies.

Author(s): Timothy Paris

Publication Date: 14 Mar 2022

Publication Site: Milliman

COVID-19 Mortality Study: Analytics – 2021 Q2

Mary Pat Campbell

Link: https://www.limra.com/en/research/benchmarks/u.s.-individual-life-insurance-covid-19-mortality-experience-study/analytics/2021-q2/

Graphic:

Excerpt:

LIMRA, Reinsurance Group of America (RGA), the Society of Actuaries (SOA) Research Institute, and TAI have collaborated on an ongoing effort to analyze the impact of COVID-19 on the
individual life insurance industry’s mortality experience and share the emerging results with the insurance industry and the public. The Individual Life COVID-19 Project Work Group (Work
Group) was formed as a collaboration of LIMRA, RGA, the SOA Research Institute, and TAI to design, implement, and create the study and to produce and distribute a variety of analyses.
This report is the fifth public release from this collaboration and contains the results of the study of excess mortality for individual life insurance to include the second quarter of 2021.
Data from 31 companies representing approximately 72% of the industry face amount in force have been included in the analysis in this report. A total of 3.0 million death claims from
individual life policies from 2015 through June 30, 2021 make up the basis of the analysis.


Highlights for the 2nd Quarter

  • The second quarter of 2021 showed a significant realignment of the actual to expected relative mortality ratios, across many different cuts of the data.
  • It is worth noting that the third quarter 2021 results will likely not be as favorable due to the impact of the COVID-19 Delta variant whose impact first started in July 2021 and peaked
    around mid- September
  • All age groups improved in the second quarter compared to the first quarter of 2021, but the improvement was more dramatic in the older ages. While the three age groups shown under
    age 65 were still significantly over the trend established by 2015-2019, the age 65-84 group was within the 95% confidence bands and the age 85+ group was significantly better than the
    2015-2019 trend (p < 0.05).
  • Whereas the pandemic experience so far had showed substantial variations across different regions, this appears to have moderated during the 2nd quarter of 2022.

Author(s): Individual Life COVID-19 Project Work Group, SOA

Publication Date: May 2022, accessed 21 May 2022

Publication Site: LIMRA

U.S. Individual Life COVID-19 Reported Claims Analysis, Fourth Quarter, 2021 Update

Mary Pat Campbell

Link: https://www.soa.org/resources/experience-studies/2022/us-ind-life-covid-q4/

PDF: https://www.soa.org/49ab0d/globalassets/assets/files/resources/research-report/2022/us-ind-life-covid-q4.pdf

Graphic:

Description:

LIMRA, Reinsurance Group of America (RGA), the Society of Actuaries Research Institute (SOA), and TAI have collaborated on an ongoing effort to analyze the impact of COVID-19 on the individual life insurance industry’s mortality experience and share the emerging results with the insurance industry and the public. This report documents a high-level analysis of the claims that have been reported through December 31, 2021. The results presented here are based on data from 32 companies representing approximately 72% of the individual life insurance in force for the experience period of the study.

Author(s): Individual Life COVID-19 Project Work Group

Publication Date: May 2022, accessed 21 May 2022

Publication Site: Society of Actuaries

2022: A Great Opportunity for the Disability Insurance Market

Mary Pat Campbell

Link: https://www.genre.com/knowledge/blog/2022-a-great-opportunity-for-the-disability-insurance-market-en.html

Graphic:

Excerpt:

Second, one of the key drivers of these stable and low benefit ratios has been steady-to-declining rates of claims incidence. In a recent paper published by the SOA and co‑authored by Gen Re’s Jay Barriss, Individual Disability incidence rates were shown to have steadily improved over the 2005 to 2015 period, relative to the latest Individual Disability Valuation Table (IDIVT) incidence rate expectations.10 The favorable incidence rate trends have likely continued into at least into 2020 as Gen Re analysis on our reinsured blocks of disability business show continuing-to-stable incidence trends since 2015.

Author(s): Mike Krohn

Publication Date: 3 May 2022

Publication Site: Gen Re